YCharts
- Novo Nordisk is now the biggest company in Europe with a valuation of more than $425 billion.
- The biotech company has taken over luxury goods maker LVMH in market cap size.
- Novo Nordisk has seen soaring demand for its weight-loss drugs Ozempic and Wegovy.
Our Chart of the Day is a comparison between the valuations of two European companies: Novo Nordisk and luxury goods maker LVMH.